Sign In to Request a Protocol
Sign In to Request a Protocol

Thymosin Alpha-1 (5 mg Vial)

  • Table of Contents

Thymosin Alpha-1 research Chart

Thymosin Alpha-1 is researched at 300 mcg–500 mcg daily via subcutaneous research methods in educational protocols. A 10 mg vial reconstituted with bacteriostatic water yields about 3.33 mg/mL. This information is for research and educational use only.

  • Reconstitute: Add 3.0 mL bacteriostatic water → ~3.33 mg/mL concentration.
  • Typical daily range: 300–500 mcg once daily (gradual titration).
  • Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 3.33 mcg on a U‑100 insulin syringe.
  • Storage: Lyophilized: refrigerate at 2–8 °C (35.6–46.4 °F) or freeze at −20 °C (−4 °F); after reconstitution, refrigerate and use within 7 days.

Thymosin Alpha-1 (Tα1) is a 28–amino acid peptide originally isolated from the thymus gland, recognized for its broad immunomodulatory properties. It has been investigated as an immune enhancer in chronic viral infections (hepatitis B/C, HIV/AIDS) and critical illness (sepsis, COVID-19). This educational protocol presents a once‑daily subcutaneous approach using a practical dilution for clear insulin‑syringe measurements.

Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety.

  • Research & Reconstitution Guide

Educational guide for reconstitution and daily research

Standard / Gradual Approach (3 mL = ~3.33 mg/mL)

Research Method: Laboratory research protocols may vary depending on the study design.

WeekDaily (mcg)Units (per mL)
Week 1300 mcg (0.3 mg)9 units (0.09 mL)
Weeks 2–8500 mcg (0.5 mg)15 units (0.15 mL)

Frequency: Research schedules, study duration, preparation methods, and experimental procedures may vary depending on the research protocol and study objectives. This information is provided for educational and research purposes only.

For ≤10‑unit (≤0.10 mL) administrations, consider 30‑ or 50‑unit insulin syringes for improved readability.

Reconstitution Steps

  • 1 . Draw 3.0 mL bacteriostatic water with a sterile syringe.
  • 2 . Procedure slowly down the vial wall; avoid foaming or direct stream onto the powder.
  • 3 . Gently swirl or roll until fully dissolved (do not shake).
  • 4 . Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

  • Research Overview
  • Peptide Vials (Thymosin Alpha-1, 10 mg each):
  • 8 weeks: 3 vials (26.6 mg total)
  • 12 weeks: 5 vials (40.6 mg total)
  • 16 weeks: 6 vials (54.6 mg total)
  • Insulin Syringes (U-100):
  • Per week: 7 syringes (1/day)
  • 8 weeks: 56 syringes
  • 12 weeks: 84 syringes
  • 16 weeks: 112 syringes
  • Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.
  • 8 weeks (3 vials): 9 mL → 1 × 10 mL bottles
  • 12 weeks (5 vials): 15 mL → 2 × 10 mL bottles
  • 16 weeks (6 vials): 18 mL → 2 × 10 mL bottles
  • Research Materials: Use appropriate laboratory materials in accordance with established research protocols.
  • Per week: 14 swabs (2/day)
  • 8 weeks: 112 swabs → recommend 2 × 100-count boxes
  • 12 weeks: 168 swabs → recommend 2 × 100-count box
  • 16 weeks: 224 swabs → recommend 3 × 100-count box
  • Protocol Overview

Concise summary of the once-daily regimen.

  • Goal: Support immune modulation and enhance host defense mechanisms.
  • Research Schedule: Study duration and research timelines may vary depending on the research protocol.
  • Research Range: 300–500 mcg daily with gradual titration.
  • Reconstitution: 3.0 mL per 5 mg vial (~1.67 mg/mL) for accurate unit measurements.
  • Storage: Lyophilized refrigerated or frozen; reconstituted refrigerated; use within 7 days.
  • Protocol Overview

Suggested daily titration approach.

  • Start: 300 mcg daily for Week 1 to assess tolerance.
  • Target: 500 mcg daily from Week 2 onward.
  • Frequency: Once per day (subcutaneous).
  • Cycle Length: 8–12 weeks; optional extension to 16 weeks.
  • Timing: Follow the study schedule and laboratory research protocol.
  • Storage Instructions

Proper storage preserves peptide quality.

  • Lyophilized: Store at 2–8 °C (35.6–46.4 °F) for short-term or −20 °C (−4 °F) for long-term; minimize moisture exposure.
  • Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 7 days when using bacteriostatic water; avoid freeze–thaw.
  • Allow vials to reach room temperature before opening to reduce condensation uptake.
  • Important Notes

Practical considerations for consistency and safety.

  • Use new sterile insulin syringes; dispose in a sharps container.
  • Research procedures and study conditions may vary depending on the research protocol.
  • Inject slowly; wait a few seconds before withdrawing the needle.
  • Document research observations and study records to maintain consistency.
  • Inspect solution before each use—do not use if cloudy or discolored.
  • How This Works

Thymosin Alpha-1 is a naturally occurring thymic peptide that modulates immune function through multiple pathways. It enhances the maturation and differentiation of T‑cells, augments dendritic cell function, and promotes the production of key cytokines including interferon‑α and interleukin‑2. Clinical studies have demonstrated Tα1’s ability to enhance immune responses in immunocompromised individuals, including those with chronic hepatitis B and C infections. Meta-analyses have also shown benefit in reducing mortality in moderate-to-critical COVID-19 patients.

  • Potential Benefits & Side Effects

Observations from preclinical and clinical literature.

  • Supports enhanced T‑cell function and overall immune competence.
  • Scientific studies have reported a favorable safety profile under controlled research conditions, with findings varying across study designs.
  • Scientific studies have reported no significant safety concerns under the research conditions evaluated, with findings varying across study designs.
  • Published research has reported varying observations under different study conditions.
  • Lifestyle Factors

Complementary strategies for best outcomes.

  • Maintain adequate sleep and stress management to support immune function.
  • Consume a nutrient‑dense diet rich in vitamins C, D, and zinc.
  • Engage in moderate physical activity to complement immune optimization.
  • Avoid excessive alcohol and smoking, which impair immune responses.
  • Research Methodology

General subcutaneous guidance from clinical best‑practice resources

  • Clean the vial stopper and skin with alcohol; allow to dry.
  • Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue.
  • Research procedures should follow the approved study design and laboratory protocols.
  • Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.
  • Important Note

This content is for therapeutic educational purposes only and is not medical advice.

  • References

World Journal of Virology

— Dominari et al. (2020): Scientific review of Thymosin Alpha-1 research, biological mechanisms, and published study findings.
More Info

Molecules (MDPI)

— Tao et al. (2023): Thymosin Alpha-1 in viral diseases—mechanisms and therapeutic applications in HBV, HCV, and HIV
More Info

Inflammopharmacology

— Soeroto et al. (2023): Meta-analysis of Tα1 in COVID-19; significant mortality reduction in moderate-to-critical patients
More Info

Expert Opinion on Biological Therapy

— Thymalfasin (Zadaxin) clinical overview: 1.6 mg SC twice weekly for hepatitis B treatment

More Info

Annals of the New York Academy of Sciences

— Thymosin Alpha-1: biological activities, clinical applications, and pharmacokinetics review
More Info

Clinical Immunology

— Mechanisms of thymosin alpha-1 immunomodulation: T-cell maturation and cytokine production
More Info

FDA Peptide Advisory Committee (2024)

— Safety data: Published research reporting safety observations under controlled study conditions.

 
More Info

Hospital Pharmacy

— Jordan et al. (2021): Scientific publication on laboratory measurement methods and research methodology.
More Info

CDC

— Vaccine administration: subcutaneous route (angle/site; no aspiration required)
More Info

Johns Hopkins Arthritis Center

— General guidance on research methodology and laboratory study procedures.
More Info

NCBI Bookshelf

— General scientific information on laboratory research methods and handling considerations.
More Info